Dabrafenib plus trametinib in patients with BRAF V600E-mutant anaplastic thyroid cancer: updated analysis from the phase II ROAR basket study - Subbiah, V; Kreitman, RJ; Wainberg, ZA (Ann Oncol, 2022)
et al.